Skip to main content

Table 1 Comparing baseline clinical, laboratory, and echocardiographic variables

From: Effect of a phase 2 cardiac rehabilitation program on obese and non-obese patients with stable coronary artery disease

Variable

Non-obese patients (n = 58)

Obese patients (n = 62)

p value

Clinical characteristics at baseline

 Age, years

54.24 ± 9.85

52.03 ± 6.48

0.313

 Female gender, n (%)

6 (10.34%)

20 (32.25%)

0.04

 Current smoker, n (%)

46 (79.31%)

32 (51.6%)

0.025

 Hypertension, n (%)

16 (27.58%)

34 (54.84%)

0.032

 Diabetes, n (%)

14 (24.13%)

24 (38.7%)

0.225

 Dyslipidemia, n (%)

14 (24.13%)

26 (41.93%)

0.144

 BMI, kg/m2

27.36 ± 1.65

33.75 ± 3.81

< 0.001

 Systolic BP, mmHg

121.03 ± 15.08

132.42 ± 16.68

0.008

 Diastolic BP, mmHg

76.38 ± 10.26

81.61 ± 9.34

0.043

 METs achieved

9.74 ± 2.47

7.97 ± 2.4

0.007

Laboratory tests at baseline

 Total cholesterol, mg/dl

170.86 ± 41.16

181.00 ± 34.48

0.304

 LDL-C, mg/dl

95.73 ± 31.51

121.63 ± 36.52

0.005

 HDL-C, mg/dl

39.34 ± 8.28

38.13 ± 8.14

0.569

 Triglycerides, mg/dl

148.86 ± 76.38

167.77 ± 60.63

0.291

 Fasting blood sugar, mg/dl

101.48 ± 24.80

109.13 ± 31.10

0.299

Echocardiographic parameters at baseline

 LVEDD, mm

52.38 ± 4.74

52.16 ± 4.51

0.856

 LVESD, mm

37.28 ± 5.52

35.97 ± 4.71

0.327

 LVEF, %

54.45 ± 8.34

56.61 ± 9.47

0.353

  1. Continuous variables are expressed as mean and standard deviation whereas categorical variables are expressed as number (percentage)
  2. BMI body mass index, BP blood pressure, METs metabolic equivalent of tasks, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, LVEDD left ventricular end-diastolic diameter, LVESD left ventricular end-systolic diameter, LVEF left ventricular ejection fraction